MYL

Mylan NV Stock Price

15.73
-0.43 (-2.66%)
Upgrade to Real-Time
Afterhours (Closed)
15.73
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Mylan NV MYL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.43 -2.66% 15.73 20:00:00
Close Price Low Price High Price Open Price Previous Close
15.73 15.61 16.19 16.16 16.16
Bid Price Ask Price Spread News
15.56 15.85 0.29 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
29,726 6,497,383 $ 15.80 $ 102,646,482 5,335,821 12.75 - 23.11
Last Trade Time Type Quantity Stock Price Currency
17:24:49 formt 85,591 $ 15.73 USD

Mylan NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 8.13B 516.95M 402.19M $ 11.50B $ 270.26M 0.03 30.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 12.50k 0.60%

more financials information »

Mylan NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MYL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week15.1516.22515.0015.855,017,0990.583.83%
1 Month16.3616.53515.0015.795,472,721-0.63-3.85%
3 Months16.2917.6915.0016.144,961,142-0.56-3.44%
6 Months14.5819.2413.24516.036,164,1391.157.89%
1 Year21.3723.1112.7517.506,277,035-5.64-26.39%
3 Years32.0247.8212.7526.335,806,246-16.29-50.87%
5 Years49.5255.50512.7532.405,799,108-33.79-68.24%

Mylan NV Description

Registered in the Netherlands, Mylan is a leading generic drugmaker, with roughly 55 manufacturing and research and development facilities. Although Mylan was formed in 1961, its position as the second- largest generic company was largely attributable to the acquisition of Matrix Laboratories and generics business of Germany-based Merck KGaA. Mylan has a portfolio of more than 7,500 generic, specialty, and over-the-counter active ingredients and medicines and is predominantly recognized for manufacturing the EpiPen (treatment for anaphylaxis), which was acquired through the Merck KGaA transaction. Unlike its peers, the company has made the most progress on the biosimilar front.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.